2012 First Quarter Review
Revenue, operating income, net income, and diluted net income per share for the 2012 first quarter as compared with the 2011 first quarter are as follows (dollar amounts in thousands except per-share data):
|
Mar. 30, |
|
$ |
% | ||||||||
|
Revenue |
$ |
103,367 |
$ |
95,909 |
$ |
7,458 |
7.8% | ||||
|
Operating income |
$ |
5,599 |
$ |
4,599 |
$ |
1,000 |
21.7% | ||||
|
Net income |
$ |
3,360 |
$ |
2,828 |
$ |
532 |
18.8% | ||||
|
Diluted net income per share |
$ |
0.20 |
$ |
0.17 |
$ |
0.03 |
17.6% | ||||
The Company's operating margin expanded by 60 basis points to 5.4% from 4.8% in the 2011 first quarter.
"This quarter's robust increases in margins and earnings primarily reflect continued growth in our health solutions business," said CTG Chairman and Chief Executive Officer
Solutions revenue in the 2012 first quarter increased by
There were 64 billing days in the first quarter of 2012 and 65 billing days in the first quarter of 2011.
Selling, general, and administrative (SG&A) expenses were
Cash used in operations was
Stock Repurchase Program
CTG repurchased 59,000 of its shares in the 2012 first quarter at an average price of
2012 Guidance
CTG is providing guidance for the 2012 second quarter and 2012 full year in the table below. Earnings guidance for the 2012 full year is unchanged while revenue guidance for 2012 has been lowered from a range of
|
2012 Second Quarter (64 billing days vs. 64 in Q2 2011) |
Range |
Range midpoint |
Change from 2011 second |
|
Revenue |
|
|
+ 6.8% |
|
Diluted net income per share |
|
|
+ 23.5% |
|
2012 Full Year (Projected tax rate of 38% to 40%)
|
Range |
Range midpoint |
Change from 2011 at range midpoint |
|
Revenue |
|
|
+ 7.2% |
|
Diluted net income per share |
|
|
+ 21.1% |
About CTG
CTG develops innovative IT solutions to address the business needs and challenges of companies in several higher-growth industries including healthcare, energy, and technology services. As a leading provider of IT and business consulting solutions to the healthcare market, CTG offers hospitals, physician groups, and regional health information exchanges a full range of electronic medical record services. Additionally, CTG has developed for the healthcare provider and payer markets unique, proprietary software solutions that support better and lower cost healthcare. CTG also provides managed services IT staffing for major technology companies and large corporations. Backed by over 45 years' experience, proprietary methodologies, and an ISO 9001-certified management system, CTG has a proven track record of delivering high-value, industry-specific solutions. CTG has approximately
3,700 employees and operates in
Safe Harbor Statement
This document contains certain forward-looking statements concerning the Company's current expectations as to future growth. These statements are based upon a review of industry reports, current business conditions in the areas where the Company does business, the availability of qualified professional staff, the demand for the Company's services, and other factors that involve risk and uncertainty. As such, actual results may differ materially in response to a change in such factors. Such forward-looking statements should be read in conjunction with the Company's disclosures set forth in the Company's 2011 Form 10-K, which is incorporated by reference. The Company assumes no obligation to update the forward-looking information contained in this release.
Conference Call and Webcast
CTG will hold a conference call to discuss its financial results and business strategy on
A live webcast of the call will be available on CTG's web site: http://www.ctg.com. The webcast will also be archived on CTG's web site at http://investor.ctg.com/events.cfm for 90 days following completion of the conference call.
Financial statements follow.
|
| ||||||||
|
For the Quarter Ended | ||||||||
|
|
April 1, | |||||||
|
2012 |
2011 | |||||||
|
Revenue |
$ |
103,367 |
$ |
95,909 | ||||
|
Direct costs |
81,515 |
76,112 | ||||||
|
Selling, general and administrative expenses |
16,253 |
15,198 | ||||||
|
Operating income |
5,599 |
4,599 | ||||||
|
Other expense, net |
(50) |
(37) | ||||||
|
Income before income taxes |
5,549 |
4,562 | ||||||
|
Provision for income taxes |
2,189 |
1,734 | ||||||
|
Net income |
$ |
3,360 |
$ |
2,828 | ||||
|
Net income per share: |
||||||||
|
|
$ |
0.22 |
$ |
0.19 | ||||
|
Diluted |
$ |
0.20 |
$ |
0.17 | ||||
|
Weighted average shares outstanding: |
||||||||
|
|
15,169 |
14,767 | ||||||
|
Diluted |
16,872 |
16,653 | ||||||
|
| ||||||||||
|
|
|
April 1, | ||||||||
|
2012 |
2011 |
2011 | ||||||||
|
Current Assets: |
||||||||||
|
Cash and cash equivalents |
$ |
19,265 |
$ |
22,414 |
$ |
8,868 | ||||
|
Accounts receivable, net |
67,799 |
67,801 |
65,339 | |||||||
|
Other current assets |
3,675 |
3,097 |
3,269 | |||||||
|
Total current assets |
90,739 |
93,312 |
77,476 | |||||||
|
Property and equipment, net |
7,659 |
7,969 |
8,544 | |||||||
|
Goodwill |
35,678 |
35,678 |
35,678 | |||||||
|
Other assets |
10,994 |
10,533 |
11,102 | |||||||
|
Total Assets |
$ |
145,070 |
$ |
147,492 |
$ |
132,800 | ||||
|
Current Liabilities: |
||||||||||
|
Accounts payable |
$ |
8,796 |
$ |
9,532 |
$ |
7,840 | ||||
|
Accrued compensation |
24,838 |
30,971 |
24,996 | |||||||
|
Other current liabilities |
7,999 |
7,423 |
6,878 | |||||||
|
Total current liabilities |
41,633 |
47,926 |
39,714 | |||||||
|
Long-term debt |
- |
- |
- | |||||||
|
Other liabilities |
10,741 |
10,761 |
9,930 | |||||||
|
Shareholders' equity |
92,696 |
88,805 |
83,156 | |||||||
|
Total Liabilities and Shareholders' Equity |
$ |
145,070 |
$ |
147,492 |
$ |
132,800 | ||||
|
| |||||||
|
For the Quarter Ended | |||||||
|
|
April 1, | ||||||
|
2012 |
2011 | ||||||
|
Net income |
$ |
3,360 |
$ |
2,828 | |||
|
Depreciation and amortization expense |
648 |
435 | |||||
|
Equity-based compensation expense |
424 |
274 | |||||
|
Other operating items |
(6,856) |
(10,693) | |||||
|
Net cash used in operating activities |
(2,424) |
(7,156) | |||||
|
Net cash used in investing activities |
(738) |
(839) | |||||
|
Net cash provided by (used in) financing activities |
(285) |
1,446 | |||||
|
Effect of exchange rates on cash and cash equivalents |
298 |
580 | |||||
|
Net decrease in cash and cash equivalents |
(3,149) |
(5,969) | |||||
|
Cash and cash equivalents at beginning of period |
22,414 |
14,837 | |||||
|
Cash and cash equivalents at end of period |
$ |
19,265 |
$ |
8,868 | |||
CTG news releases are available on the Web at www.ctg.com.
ctgx-e
SOURCE CTG
News Provided by Acquire Media